Tyra Biosciences, Inc. (TYRA)
CIK 1863127 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tyra Biosciences, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Oct 27, 2026 | SCHEDULE 13G/A | 0002012383-26-003856 |
| Sep 21, 2026 | SCHEDULE 13G | 0000921895-26-002613 |
| Sep 17, 2026 | 4 | 0001193125-26-394738 |
| Sep 17, 2026 | 4 | 0001193125-26-394734 |
| Sep 17, 2026 | SCHEDULE 13D/A | 0001346824-26-000237 |
| Sep 17, 2026 | 4 | 0001231919-26-001194 |
| Sep 17, 2026 | SCHEDULE 13G | 0001104659-26-108569 |
| Sep 17, 2026 | 4 | 0001193125-26-394731 |
| Sep 15, 2026 | 8-K | 0001193125-26-390951 |
| Sep 15, 2026 | 424B5 | 0001193125-26-390947 |
| Sep 14, 2026 | S-3ASR | 0001193125-26-389752 |
| Sep 14, 2026 | FWP | 0001193125-26-389801 |
| Sep 11, 2026 | 4 | 0001193125-26-389333 |
| Sep 9, 2026 | 8-K | 0001193125-26-385886 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0000908834-26-000427 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001804218-26-000003 |
| Aug 4, 2026 | 8-K | 0001193125-26-332752 |
| Aug 4, 2026 | 10-Q | 0001193125-26-332995 |
| Aug 4, 2026 | 424B5 | 0001193125-26-333055 |
| Jul 30, 2026 | SCHEDULE 13G | 0002012383-26-003114 |
| Jun 26, 2026 | 144 | 0001628280-26-045813 |
| Jun 2, 2026 | 8-K | 0001193125-26-253435 |
| Jun 1, 2026 | 144 | 0001628280-26-039506 |
| Jun 1, 2026 | 4 | 0001193125-26-251532 |
| Jun 1, 2026 | 4 | 0001231919-26-000590 |